Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2B | $1.8B | $1.9B | $486M | $504M | |
| Gross Profit | $969M | $827M | $909M | $220M | $243M | |
| Operating Income | -$82M | -$371M | -$386M | -$112M | -$109M | |
| EBITDA | $441M | $135M | $128M | $15M | $20M | |
| Diluted EPS | -$0.07 | -$3.65 | -$0.41 | -$3.35 | -$0.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $2.2B | $1.9B | $2.1B | $2.4B | |
| Total Assets | -- | $16.2B | $15.5B | $12.6B | $12.5B | |
| Current Liabilities | -- | $4.8B | $391M | $362M | $374M | |
| Total Liabilities | -- | $5B | $632M | $525M | $545M | |
| Total Equity | -- | $11.2B | $14.9B | $12.1B | $11.9B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $418.7M | $299.4M | $716M | $125.8M | $188M | |
| Cash From Investing | $760.9M | -$119.5M | -$89.3M | -$34.1M | -$27.8M | |
| Cash From Financing | -$858.8M | -$84.3M | -$156.7M | -$5M | -$106.7M | |
| Free Cash Flow | $315.8M | $209.7M | $648.4M | $103.7M | $161.7M | |
Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.
In the current month, MBLY has received 13 Buy ratings 10 Hold ratings, and 0 Sell ratings. The MBLY average analyst price target in the past 3 months is $18.93.
According to analysts, the consensus estimate is that Mobileye Global, Inc. share price will rise to $18.93 per share over the next 12 months.
Analysts are divided on their view about Mobileye Global, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mobileye Global, Inc. is a Sell and believe this share price will drop from its current level to $12.00.
The price target for Mobileye Global, Inc. over the next 1-year time period is forecast to be $18.93 according to 23 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Mobileye Global, Inc. is a Buy. 13 of 23 analysts rate the stock a Buy at this time.
You can purchase shares of Mobileye Global, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mobileye Global, Inc. shares.
Mobileye Global, Inc. was last trading at $10.17 per share. This represents the most recent stock quote for Mobileye Global, Inc.. Yesterday, Mobileye Global, Inc. closed at $10.17 per share.
In order to purchase Mobileye Global, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.